Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study

Effective and tolerable treatments are needed for older patients with classical Hodgkin lymphoma. We report results for older patients with classical Hodgkin lymphoma treated in the large phase III ECHELON-1 study of frontline brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD...

Descripción completa

Detalles Bibliográficos
Autores principales: Evens, Andrew M., Connors, Joseph M., Younes, Anas, Ansell, Stephen M., Kim, Won Seog, Radford, John, Feldman, Tatyana, Tuscano, Joseph, Savage, Kerry J., Oki, Yasuhiro, Grigg, Andrew, Pocock, Christopher, Dlugosz-Danecka, Monika, Fenton, Keenan, Forero-Torres, Andres, Liu, Rachael, Jolin, Hina, Gautam, Ashish, Gallamini, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052913/
https://www.ncbi.nlm.nih.gov/pubmed/34162178
http://dx.doi.org/10.3324/haematol.2021.278438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052913/
https://www.ncbi.nlm.nih.gov/pubmed/34162178
http://dx.doi.org/10.3324/haematol.2021.278438

Ejemplares similares